Seymour Tamara A
- SEC CIK
- 0001288232
No open-market purchases or sales filed in the past year.
Current role at each company
- ARTL Artelo Biosciences, Inc.Directoras of Jul 21, 2026
- ZVRA Zevra Therapeutics, Inc.Directoras of Jun 18, 2026
- HURA TuHURA Biosciences, Inc.Directoras of Sep 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Seymour Tamara A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZVRA Zevra Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 (view filing) | Sep 12 | 4 days | Seymour Tamara ADirector | PPurchase | +3.17K | $7.79 | +$24.7K | +441.6%3.89K after | |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Seymour Tamara ADirector | PPurchase | +519 | $4.82 | +$2.50K | +259.5%719 after | |
| May 24, 2022 (view filing) | May 20 | 4 days | Seymour Tamara ADirector | PPurchase | +200 | $4.87 | +$974 | New position200 after |
ARTL Artelo Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | May 1 | 4 days | Seymour Tamara ADirector | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |